RecruitingNot applicableNCT03555578

Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

Studying Kennedy disease

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Takeda
Principal Investigator: Study Director
Takeda
Intervention: Leuprorelin Acetate(drug)
Enrollment: 1890 enrolled
Eligibility: All sexes
Timeline: 2017 – 2026

Study locations (1)

Takeda Selected Site, Tokyo, Japan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03555578 on ClinicalTrials.gov

Other trials for Kennedy disease

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2, PHASE3NCT06862596
Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy
Masahisa Katsuno
ACTIVE NOT RECRUITINGNCT07443449
International SBMA Project (KDA)
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
RECRUITINGPHASE2NCT06169046
A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy
Gianni Soraru
RECRUITINGNANCT04944940
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
National Institute of Neurological Disorders and Stroke (NINDS)
RECRUITINGNCT05966038
ALS/MND Natural History Study Data Repository
Massachusetts General Hospital

See all trials for Kennedy disease →

← Back to all trials